Welcome to our dedicated page for Elevance Health news (Ticker: ELV), a resource for investors and traders seeking the latest updates and insights on Elevance Health stock.
Elevance Health, Inc. (ELV) maintains this dedicated news hub for stakeholders tracking developments in health insurance innovation and corporate strategy. Access official press releases, regulatory filings, and operational updates from one of America's largest managers of Blue Cross Blue Shield plans and government-sponsored healthcare programs.
This resource provides investors with timely updates on earnings reports, Medicare Advantage expansions, and strategic partnerships. Analysts will find detailed information about risk management initiatives and market positioning within the competitive healthcare coverage sector.
Key content categories include quarterly financial disclosures, Medicaid program developments, provider network enhancements, and technology investments. All materials are sourced directly from corporate communications to ensure accuracy and compliance with financial reporting standards.
Bookmark this page for streamlined access to Elevance Health's latest announcements. Combine these updates with SEC filings and industry analysis for comprehensive due diligence on this leading health benefits administrator.
Elevance Health has released its annual Impact Report, showcasing its transformation from a traditional health insurance company to a comprehensive healthcare services provider. Key achievements include receiving the Health Equity Accreditation Plus from the National Committee for Quality Assurance, supporting Medicaid eligibility renewals, and expanding Carelon. The company was recognized among America’s top 50 most community-minded companies and featured in JUST Capital’s JUST 100. The report emphasizes Elevance Health’s efforts to cater to the unique needs of each health plan member, assess and address health drivers, form community partnerships, and utilize data-driven insights to enhance and personalize healthcare services.
Elevance Health (NYSE: ELV) will announce its second quarter 2024 financial results on July 17, 2024, at 6:00 a.m. EDT. A conference call to discuss these results and the company's outlook will follow at 8:30 a.m. EDT. The domestic access number for the call is 888-947-9963 with the access code 3972058, and for international participants, the number is 312-470-0178 with the same access code. A replay of the call will be available domestically at 800-391-9851 and internationally at 203-369-3268 from 11:30 a.m. EDT on July 17 until August 17, 2024. Additionally, the call will be accessible via a live webcast on the Elevance Health website under the 'Investors' section.
Elevance Health (NYSE: ELV) will present at Goldman Sachs 45th Annual Global Healthcare Conference in Miami Beach, Florida on June 12 at 1:20 p.m. EDT. Senior management will deliver the presentation, which will be webcast live on the company's investor relations website. A replay of the presentation will be available for 90 days following the event. Interested individuals are advised to visit the website early to download any necessary software. This presentation will reflect Elevance Health's recent SEC filings, including their Annual Report on Form 10-K for the year ending December 31, 2023.
Elevance Health (NYSE: ELV) announced its participation in Bernstein's 40th Annual Strategic Decisions Conference in New York City on May 31 at 9:00 a.m. EDT.
Senior management will present critical company updates. Interested parties can access a live webcast through Elevance Health's investor site.
A replay will be available for 90 days post-presentation.
Listeners are advised to review Elevance Health's recent SEC filings, including the 2023 Annual Report on Form 10-K.
FAQ
What is the current stock price of Elevance Health (ELV)?
What is the market cap of Elevance Health (ELV)?
